COMMISSION OF THE EUROPEAN COMMUNITIES 
Brussels, 06.05.1997 
COM(97) 205 final 
97/0131 (ACQ 
Proposal for a 
COUNCIL DECISION 
authorizing conclusion, on behalf of the Community, of an agreement on drugs 
precursors and chemical substances 
between the European Community and the United States of America 
(presented by the Commission) 

1. EXPLANATORY MEMORANDUM 
By Decision of 25 September 1995 (Doc. 9782/95), the Council authorized the 
Commission to negotiate on behalf of the Community agreements on the control of 
drugs precursors and chemical substances with the member states of the OAS. A first 
series of agreements was concluded on 18 December 1995 with the member countries 
of the Cartagena agreement *. A further agreement was signed with Mexico on 13 
December 1996 2. 
The above decision was taken to prevent the diversion of chemical substances 
frequently used for the illicit manufacture of narcotic drugs and psychotropic 
substances, which most commonly occurs in international trade between the chemical 
exporting countries and those countries concerned with illicit drugs manufacture on 
their own or a neighbouring territory. 
The decision was preceded by close contacts with the relevant authorities of the OAS 
member countries during which the wish to conclude such agreements had been 
repeatedly expressed. Over the years, particularly close relationships have been 
developped with the United States, on the basis of the fact that the transatlantic 
partners are together responsible for approximately 80% of the world trade in 
chemicals. Both sides felt that there was a need not only to monitor bilateral EC-US 
trade in the substances concerned but also to consult each other on chemical shipments 
to high risk destinations in third countries. Therefore, specific provisions have been 
included for this purpose in the agreement. 
In compliance with the above-mentioned decision, the Commission has negotiated an 
agreement with the United States of America which was initialled on 11.04.1997. It is 
therefore necessary to proceed to the signature and the conclusion of the Agreement. 
The Agreement provides for the possibility of modifying the lists of substances subject 
to the trade surveillance mechanisms referred to in Article 2 of the Agreement and 
which are contained in the Annexes to the Agreement. Such modification may include 
changes in the number of substances as well as the transfer of substances from one 
Annex to the other. 
Where such modifications only concern substances already covered by the relevant 
Community legislation on drugs precursors and chemical substances, the Commission 
is authorized to approve such modifications on behalf of the Community. The Council 
will designate a Special Committee to assist the Commission in this task. 
1 cf. OJL 324 of 30.12.95 
2 cf. OJ L 77 of 19.03.97 
The Council is therefore requested to 
- approve the Agreement between the European Community and the United States of 
America on Drugs Precursors and Chemical Substances on behalf of the Community; 
- designate a person empowered to sign the Agreement; 
- authorize the Commission, in consultation with a special committee appointed by the 
Council, to approve modifications on behalf of the Community where the Agreement 
provides for them to be adopted by the Joint Follow-Up Group; however, such 
authorization will be limited to the modification of the Annexes of the Agreement 
insofar as it concerns substances already covered by the Community legislation on 
drugs precursors and chemical substances. 
2, 
Council Decision 
authorizing conclusion, on behalf of the Community, of an agreement on drugs 
precursors and chemical substances 
between the European Community and the United States of America 
THE COUNCIL OF THE EUROPEAN UNION; 
Having regard to the Treaty establishing the European Community, and in particular 
Article 113, in conjunction with the first sentence of Article 228 (2), and Article 228 
(4) thereof, 
Having regard to the proposal from the Commission, 
Whereas, on 25 September 1995, the Council authorized the Commission to negotiate. 
on behalf of the Community, agreements on the control of drugs precursors and 
chemical substances with the Member States of the OAS, 
Whereas the Transatlantic Agenda identified as a priority item in EC-US relations, the 
conclusion of a drugs precursors agreement which would include a specific pre 
shipment consultation mechanism. 
Whereas the Commission, on the basis of this authorization and the provisions of the 
Transatlantic Agenda, completed negotiations with the United States of America on 
11.04.1997. 
Whereas it is appropriate that the Council authorizes the Commission, in consultation 
with a special committee appointed by the Council, to approve modifications on 
behalf of the Community where the Agreement provides for them to be adopted by the 
Joint Follow-Up Group; however, such authorization will be limited to the 
modification of the Annexes of the Agreement insofar as it concerns substances 
already covered by the Community legislation on drugs precursors and chemical 
substances. 
HAS ADOPTED THIS DECISION: 
Article 1 
1. The agreement between the European Community and the United States of America 
on the control of drugs precursors and chemical substances is approved on behalf of 
the Community. 
2. The text of the Agreement is attached to this Decision. 
H-
Article 2 
The President of the Council is hereby authorized to designate the person empowered 
to sign the agreement negotiated with the United States of America on the control of 
drugs precursors and chemical substances. 
Article 3 
1. The Community shall be represented in the Joint Follow-Up Group provided for in 
Article 11 of the Agreement by the Commission, assisted by the representatives of the 
Member States. 
2. The Commission is authorized to approve, on behalf of the Community, 
modifications of the Annexes to this Agreement adopted by the Joint Follow-Up 
Group by the procedure laid down in Article 12 of the Agreement. 
The Commission is assisted in this task by a special committee designated by the 
Council. 
3. The authorization referred to in Paragraph 2 shall be limited to those substances 
which are already covered by the relevant Community legislation on drugs precursors 
and chemical substances. 
Done at Brussels For the Council 
AGREEMENT 
between the European Community 
and 
the United States of America 
on precursors and chemical substances frequently used in the 
illicit manufacture of narcotic drugs or psychotropic substances 
THE EUROPEAN COMMUNITY, hereinafter referred to as the "Community", on 
the one part, and 
THE UNITED STATES OF AMERICA, hereinafter referred to as the "United 
States", on the other part, 
DETERMINED to prevent and combat the illicit manufacture of narcotic drugs and 
psychotropic substances by controlling the supply of precursors and chemical 
substances frequently used for such purposes; 
ACKNOWLEDGING Article 12 of the United Nations Convention of 1988 against 
Illicit Traffic in Narcotic Drugs and Psychotropic Substances; 
AGREEING with the final Report of the Chemical Action Task Force (CATF), 
approved by the London G-7 Economic Summit on 15 July 1991, which 
recommended the strengthening of international cooperation by the conclusion of 
bilateral agreements, in 
particular between regions and countries involved in export, import and transit of 
these chemical substances; 
CONVINCED that international trade constitutes a specific risk factor and that only 
cooperative arrangements between the regions concerned can prevent this danger, in 
particular by linking export and import controls; 
AFFIRMING their common commitment to setting up assistance and co-operation 
mechanisms between the United States and the Community in order to combat the 
diversion of controlled substances to illicit purposes, in harmony with the orientations 
and actions decided at the international level; 
UNDERLINING their common will to improve the current information exchange 
between relevant agencies, and without disturbing the existing working relations 
between them; 
RECOGNIZING that these chemical substances are also mainly and widely used for 
legitimate purposes and that international trade must not be hindered by excessive 
monitoring procedures; 
HAVING DECIDED to conclude an Agreement for the control of precursors and 
chemical substances frequently used in the illicit manufacture of narcotic drugs or 
psychotropic substances; 
HAVE AGREED AS FOLLOWS: 
Article 1 
Scope of the Agreement 
1. This Agreement sets out measures to strengthen administrative co-operation and 
to improve working relations between the Contracting Parties to prevent the 
diversion of substances frequently used in the illicit manufacture of narcotic drugs 
or psychotropic substances, without prejudice to the due recognition of the 
legitimate interests of trade and industry. 
Nothing in this Agreement: 
- may be interpreted in a manner which is inconsistent with the UN international 
drug control treaties, or 
- shall disturb existing working law enforcement relations in drug-related matters 
between the United States and the Member States of the European Community. 
2 For this purpose, the Contracting Parties shall assist each other, as set out in this 
Agreement, notably in: 
- monitoring the trade between them in scheduled substances, with the aim of 
preventing their diversion to illicit purposes, 
- granting each other the means of mutual consultation on the legitimacy of 
proposed transactions in scheduled substances destined for third countries, and 
- providing mutual administrative assistance to ensure that the provisions of the 
relevant substance trade control legislation are correctly applied. 
3. Without prejudice to possible amendments which might be adopted within the 
competence of the Joint Follow-up Group, this Agreement applies to the chemical 
substances listed in the Annex to the 1988 UN Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances as amended, hereinafter referred to 
as "controlled chemical substances". 
? J*-
Title I 
Trade in controlled chemical substances between the 
Contracting Parties 
Article 2 
Trade surveillance 
1. The Contracting Parties shall consult and inform each other on their own initiative 
of any suspicion that controlled chemical substances may be diverted from 
legitimate trade between them to the illicit manufacture of narcotic drugs or 
psychotropic substances, in particular when a shipment occurs in unusual 
quantities or under unusual circumstances. 
2. With regard to the controlled chemical substances listed in Annex A to this 
Agreement, the competent authority of the exporting Contracting Party shall, at 
the same time as the export authorization is issued or a notification of export is 
received, and as soon as possible, forward a copy of this information to the 
competent authority of the importing Contracting Party. Specific information 
shall be provided where the operator benefits, in the exporting country, from an 
open individual authorization covering multiple export operations. 
3. • With regard to the controlled chemical substances listed in Annex B to this 
Agreement, the export shall be authorized only when the importing Contracting 
Party has given its consent. 
4. The Contracting Parties undertake to provide, reciprocally and in good time, due 
feedback on any information provided or measure requested under this Article. 
J^ h-
When implementing the above-mentioned trade control measures, the legitimate 
interests of trade shall be duly respected. In particular, in cases covered by paragraph 
3, the reply by the importing Contracting Party shall be provided within 15 working 
days after the reception of the message from the exporting Contracting Party. The 
absence of a reply within this time period shall be deemed as granting an import 
authorization. The refusal to grant an import authorization shall be notified in writing, 
including electronic means, to the exporting Contracting Party within this time period 
and the reasons for it must be documented. 
Article 3 
Suspension of shipment 
1. Without prejudice to any possible implementation of technical enforcement measures, 
shipments shall be suspended if, in the opinion of either Contracting Party, there are 
reasonable grounds to believe that controlled chemical substances may be diverted to 
the illicit manufacture of narcotic drugs or psychotropic substances. 
The Contracting Parties shall co-operate in supplying each other with information 
relating to suspected diversion operations. 
Title n 
Trade in controlled chemical substances with other countries 
Article 4 
Pre-shipment consultation 
1. Without prejudice to Articles 6, 7 and 8, whenever a competent authority, in 
processing a request for an export authorization to a third country, suspects that the 
controlled chemical substances involved may be diverted to illicit drugs manufacture, 
appropriate information should normally be relayed to the other Contracting Party to 
this Agreement, with the request to the competent authority of this Contracting Party 
for relevant information in its possession which may confirm or refute the possible 
diversion. 
2. To comply with the request mentioned in Paragraph 1, provided that the necessary 
information has been made available, the requested Contracting Party shall search 
its databases or other available sources for information relating to the case and 
communicate its findings to the requesting Contracting Party. Whenever possible, 
the reply should be given within five working days after receipt of the request. 
3. The requesting authority, on its own responsibility and with due assessment of all 
the elements of the case, shall determine whether to authorize, deny or take other 
action concerning the export in question. It shall then notify the requested 
authority of the decision taken. 
4. The Contracting Parties shall immediately notify each other of any decision to 
stop a shipment of controlled chemical substances to third countries, which they 
believe may be of interest to the other Contracting Party, and shall provide such 
information regarding the shipment as appropriate. 
Article 5 
Other information 
Without prejudice to Articles 6, 7 and 8, the Contracting Parties shall periodically 
exchange other data and information concerning trends and circumstances as seem 
desirable to achieve the purposes of this Agreement. 
Tide III 
General provisions 
Article 6 
Mutual administrative assistance 
1. The Contracting Parties shall supply to each other, either on their own initiative or 
on request, information to prevent the diversion of controlled chemical substances 
to the illicit manufacture of narcotic drugs or psychotropic substances and shall 
investigate cases of suspected diversion. When necessary, they shall adopt 
appropriate precautionary measures to prevent diversion. 
2. Any request for information or precautionary measures shall be responded to as 
promptly as possible. 
3. Requests for administrative assistance shall be executed in accordance with the 
laws, regulations and other legal instruments of the requested Contracting Party. « 
4. Officials of a Contracting Party may, with the agreement of the other Contracting 
Party, be present at the inquiries carried out in the territory of the latter. 
5. The Contracting Parties shall assist each other to facilitate the provision of 
evidence. 
6. Administrative assistance provided under this Article shall not prejudice the rules 
governing mutual legal assistance in criminal matters, nor shall it apply to 
information obtained under powers exercised at the request of a judicial authority, 
unless the authority so agrees. 
7. Information may be requested in respect of chemical substances which are 
frequently used in the illicit manufacture of narcotic drugs or psychotropic 
substances but which are not included in the scope of this Agreement. 
Article 7 
Information exchange and confidentiality 
1. Data relating to natural persons may be exchanged only where the receiving 
Contracting Party undertakes to afford such data with at least substantially the 
same level of protection as the one applicable to that particular instance in the 
Contracting Party liable to supply them. To this end, the Contracting Parties shall 
provide each other with information setting forth the applicable standards of the 
Contracting Parties, including where appropriate the legal standards of the 
Member States of the Community. 
2. Any information communicated in whatsoever form pursuant to this Agreement 
shall be of a confidential or restricted nature, depending on the rules applicable in 
each of the Contracting Parties, and shall be used solely for the purposes of this 
Agreement. Such information shall be afforded in the receiving Contracting Party 
the same protection in respect of confidentiality and official secrecy as applies in 
that Contracting Party to similar information under the relevant laws of the 
Contracting Party which received it. 
3. Assistance may be postponed, or provided with conditions, on the ground that it 
would otherwise interfere with an ongoing investigation, prosecution or 
proceeding, or jeopardize the security of sensitive sources and methods of 
gathering information. In such a case, the authority which could provide 
assistance shall consult with the competent authority of the other Contracting 
Party to determine if assistance can be given subject to such terms or conditions 
as the providing authority may require. 
// 
Information obtained shall be used solely for the purposes of this Agreement. 
Where one of the Contracting Parties requests the use of such information for 
other purposes, it shall ask for the prior written consent of the authority which 
furnished the information. Moreover, such use shall be subject to any restrictions 
laid down by that authority. 
Paragraph 4 shall not impede the use of information in any judicial or 
administrative proceedings subsequently instituted for failure to comply with 
substance control legislation. The competent authority which supplied that 
information shall be notified of such use. 
Article 8 
Exceptions to the obligation to provide assistance 
1. The Contracting Parties shall make every reasonable effort to routinely provide 
requested information and assistance. 
2. In cases where the requested Contracting Party is of the opinion that compliance 
with the request would: 
- infringe upon the sovereignty of the United States or of a Member State of the 
Community, or 
- present a serious issue of public policy, security or other essential interests, in 
particular the cases referred to in Article 7(1) concerning natural persons, and in 
Article 7(3) concerning ongoing investigations, prosecutions or proceedings and 
the security of sensitive sources and methods of gathering information, or 
- be contrary to the legal system of the requested Contracting Party, including, 
where appropriate, the legal system of the Member States of the Community 
liable to provide the assistance, assistance can be refused or compliance may be 
made subject to the satisfaction of certain conditions or requirements. 
If one Contracting Party requests assistance which it could not itself supply 
entirely or partially pursuant to a similar request, it shall so state in its request. 
The other Contracting Party shall then decide in what form it can comply with the 
request. 
If assistance is refused under this Article, the decision and its explanatory reasons 
shall be communicated without delay to the other Contracting Party. 
43. 
Article 9 
Technical and scientific co-operation 
The Contracting Parties shall co-operate in the identification of new diversion 
methods as well as appropriate countermeasures, including technical co-operation to 
strengthen administrative and enforcement structures in this field and to promote co­
operation with trade and industry. Such technical co-operation may concern, in 
particular, training and exchange programmes for the officials concerned. 
Article 10 
Implementation measures 
Each Contracting Party shall identify a competent authority or competent 
authorities to co-ordinate the application of this Agreement. These authorities 
shall communicate directly with one another for the purposes of this Agreement. 
The Contracting Parties shall keep each other informed of the provisions which 
they adopt for the implementation of this Agreement. 
Article 11 
Joint Follow-up Group 
A Joint Follow-up Group on the control of precursors and chemical substances is 
hereby established, hereinafter referred to as "the Joint Follow-up Group", in 
which each Contracting Party to this Agreement shall be represented. 
2. The Joint Follow-up Group shall act by mutual agreement. It shall normally meet 
once a year, date, place and programme being fixed by mutual agreement. 
Extraordinary meetings of the Joint Follow-up Group may be convened by 
agreement of the Contracting Parties. 
3. The Joint Follow-up Group shall adopt its own rules of procedure. 
fl 
Article 12 
Role of the Joint Follow-up Group 
1. The Joint Follow-up Group shall monitor the administration of this Agreement 
and ensure its proper implementation. For this purpose: 
• - it shall study and develop the necessary means to ensure the correct functioning 
of the present Agreement, 
- it shall be regularly informed by the Contracting Parties of their experience in 
applying this Agreement, 
- in the cases provided for in Paragraph 2, it shall take decisions, 
- in the cases provided for in Paragraph 4, it shall make recommendations, 
- it shall study and develop the co-operation measures referred to in Article 9, and 
- it shall study and develop other possible forms of co-operation in matters 
relating to precursors and chemical substances. 
2. The Joint Follow-up Group shall adopt by mutual consent decisions to amend 
Annexes A and B. 
Such decisions shall be implemented by the Contracting Parties in accordance 
with their own legislation. 
If, in the Joint Follow-up Group, a representative of a Contracting Party has 
accepted a decision subject to the completion of procedures necessary for that 
purpose, the decision shall enter into force, if no date is contained therein, on the 
first day of the second month after such a completion is notified. 
3. The Joint Follow-up Group shall adopt, by mutual consent, the procedures to be 
followed in pre-shipment consultations laid down in Article 4. 
4 .The Joint Follow-up Group shall recommend to the Contracting Parties: 
- amendments to this Agreement, and 
- any other measures required for the implementation of this Agreement. 
H 
Article 13 
Other agreements 
1. As regards controlled chemical substances, and subject to Article 7(3), nothing in 
this Agreement or in other agreements concluded between the Community and the 
United States shall prejudice Community provisions governing the 
communication between the competent administrative authorities within the 
Community of any information obtained in matters covered by this Agreement 
which could be of Community interest. 
2. Nothing in this Agreement shall prejudice the provisions of any Mutual Legal 
Assistance Treaty between the United States and any Member State of the 
Community. 
3. The Contracting Parties shall also exchange information with each other on 
measures in substance control matters taken with other countries. 
Article 14 
Entry into force 
This Agreement shall enter into force on the first day of the second month following 
the date of signature. 
Article 15 
Duration and denunciation 
1. This Agreement shall be concluded for five years and, unless otherwise 
terminated, it shall be automatically renewed for successive five-year periods. 
2. This Agreement may be amended by mutual consent of the Contracting Parties. 
3. This Agreement may be terminated at any time by either Contracting Party upon 
90 days' written notice. 
fb 
Article 16 
Authentic texts 
This Agreement is drawn up in duplicate in the Danish, Dutch, English, Finnish, 
French, German, Greek, Italian, Portuguese, Spanish and Swedish languages, all texts 
being equally authentic. 
IN WITNESS WHEREOF, the undersigned, being duly authorized, have signed this 
Agreement. 
DONE at , on 
FOR THE EUROPEAN COMMUNITY: 
Mr.... [to be designated] 
Minister for... 
President-in-Office 
Mr. ... [to be designated] 
Minister for... 
FOR THE UNITED STATES OF AMERICA: 
Mr./Ms. ... [to be designated] 
[to be designated] 
<L y 
ANNEX A: 
Substances subject to the measures referred to in Article 2(2) 
Ephedrine 
Ergometrine 
Lysergic acid 
1 -phenyl-2-propanone (phenylacetone) 
Pseudoephedrine 
Acetylanthranilic acid (2-Acetamidobenzoic acid) 
3,4 Methylenedioxy-phenylpropan-2-one 
Isosafrole ( 
Piperonal 
Safrole 
Phenylacetic acid 
Piperidine 
ANNEX B: 
Substances subject to the measures referred to in Article 2(3) 
n i 
Joint statement bv the Contracting Parties 
concerning Article 7(H 
The Contracting Parties agree to convene a meeting of the Joint Follow-Up Group as 
soon as possible after the entry into force of this Agreement in order to reach a 
common interpretation of the necessary criteria to be complied with concerning the 
relevant levels of protection to be applied under Article 7(1). 
They stress that such a common interpretation is indispensable to respect the legal 
system referred to in Article 8(2). 
The Contracting Parties further stress their common basis for trust and co-operation 
and the desirability for ensuring a common and mutually complementary application 
of the provisions of this Agreement. 
Side Instrument concerning Article 13 
Letter by the Community 
With respect to the Chemical Control Agreement between the European 
Community and the United States of America, the Contracting Parties agree that, to 
the best of their collective knowledge, they cannot identify any bilateral executive 
agreements, memoranda of understanding, or other similar instruments between the 
United States and individual Member States of the Community that specifically 
address the issue of controlled chemical substances. Thus, the present Agreement is 
the only agreement that specifically addresses the issue of controlled chemical 
substances in the field of administrative cooperation. 
The European Community states that, under the provisions of the Treaty on 
the European Union, and in particular Article 228, Paragraph 7 thereof, insofar as 
provisions of bilateral executive agreements, memoranda of understanding, or other 
similar instruments that may have been previously concluded between any of the 
Member States of the Community and the United States are incompatible with those 
of this Agreement, the latter shall govern insofar as the incompatibility concerns the 
exclusive competence of the Community as exercised through Community legislation 
referring to controlled chemical substances. 
However, the provisions of these other agreements between Member States of 
the Community and the United States are not affected insofar as they address issues 
which fall within the scope of Title VI of the Treaty on the European Union. When 
there are uncertainties as to the applicability of this Agreement or the provisions of 
any such complementary agreements, the Contracting Parties will consult promptly 
and take appropriate steps to resolve the matter. 
n JL 
Reply by the United States 
I have the honor to acknowledge receipt of your letter, dated today, concerning 
the applicability of the US-EC Agreement on precursors and chemical substances 
frequently used in the illicit manufacture of narcotic drugs or psychotropic substances, 
which reads as follows: 
"With respect to the Chemical Control Agreement between the European 
Community and the United States of America, the Contracting Parties agree that, to 
the best of their collective knowledge, they cannot identify any bilateral executive 
agreements, memoranda of understanding, or other similar instruments between the 
United States and individual Member States of the Community that specifically 
address the issue of controlled substances. Thus, the present Agreement is the only 
agreement that specifically addresses the issue of controlled chemical substances in 
the field of administrative cooperation. 
The European Community states that, under the provisions of the Treaty on 
the European Union, and in particular Article 228, Paragraph 7 thereof, insofar as 
provisions of bilateral executive agreements, memoranda of understanding, or other 
similar instruments that may have been previously concluded between any of the 
Member States of the Community and the United States are incompatible with those 
of this Agreement, the latter shall govern insofar as the incompatibility concerns the 
exclusive competence of the Community as exercised through Community legislation 
referring to controlled chemical substances. 
However, the provisions of these other agreements between Member States of 
the Community and the United States are not affected insofar as they address issues 
which fall within the scope of Title VI of the Treaty on the European Union. When 
there are uncertainties as to the applicability of this Agreement or the provisions of 
any such complementary agreements, the Contracting Parties will consult promptly 
and take appropriate steps to resolve the matter." ' 
The United States shares the common understandings recorded in that letter 
and takes note of the EC statement contained therein. The United States confirms 
that, in the event of a question regarding the possible compatibility of provisions of 
this Agreement and of other bilateral executive agreements, memoranda of 
understanding, or other similar instruments, it stands ready to consult promptly with 
the Community with a view to a satisfactory resolution of the question. 
iS V 
FINANCIAL STATEMENT 
concerning the signature and conclusion of Agreements 
on the Control of Drugs Precursors and Chemical Substances 
between the European Community and 
the member countries of the Organization of American States (OAS)j 
including the United States of America 
Please note that this operation is fully covered by the financial statement on 
the operation "Negotiation of precursor control agreements with the member 
countries of the Organization of the American States (OAS)" as approved by 
the Council in its decision of 25 September 1995. There are no additional 
resource needs for the current operation. 
In this context, it should be noted, that no resources for technical assistance 
will be required in the case of the United States (North-South co-operation 
schemes under B7-6210 not being applicable in this case). 
1. Title of operation 
Signature and conclusion of agreements on the Control of Drugs Precursors and 
Chemical Substances between the European Community and the member countries of 
the Organization of American States (OAS), including the United States . 
2. Budget heading involved 
A1,A2,A4,A5 Staff expenditure 
A-l 30 Mission expenses, travel expenses and 
incidental expenditure incurred by Commission staff 
A-250 Meetings in general 
3. Legal basis 
Article 113 of the EC Treaty 
Council Regulation (EEC) No 3677/90 of 13 December 1990 (OJ No L 357 of 
20.12.90, p.l), as last amended by Council Regulation (EEC) No 900/92 of 31 
March 1992 (OJ No L 96 of 10.4.92, p.l), and implemented by Commission 
Regulation (EEC) No 3769/92 of 21 December 1992 (OJ No L 383 of 
29.12.92, p. 17), as last amended by Commission Regulation (EEC) 
No 2959/93 (OJ No L 267 of 28.10.93, p.8) 
2o 
4. Description of operation 
4.1 General objective 
To establish co-ordinated trade controls on drugs precursors for the benefit of 
both parties and thereby strengthen as transatlantic partnership in anti-drugs 
matters 
4.2 Period covered and arrangements for renewal 
5 years, with tacit annual renewal thereafter. 01.07.1997 - 30.06.2002 
5. Classification of expenditure or revenue 
6. Type of expenditure or revenue 
7. Financial impact 
not applicable 
7.1 Method of calculating total cost of operation (relation between individual and 
total costs) 
7.2 Itemised breakdown of cost 
7.3 Schedule of commitment and payment appropriations 
8. Fraud prevention measures 
9. Elements of cost-effectiveness analysis 
9.1 Specific and quantified objectives; target population 
9.2 Grounds for the operation 
9.3 Monitoring and evaluation of the operation 
10. Administrative expenditure (Section III, Part A of the budget) 
Actual mobilization of the necessary administrative resources will depend on the 
Commission's annual decision on the allocation of resources, taking into account the 
number of staff and additional amounts authorized by the budgetary authority. 
at 
10.1 Effect on the number of posts 
Type of post 
Officials or 
temporary 
staff A 
B 
C 
Other resources 
Total Staff to be assigned to 
managing the operation 
Permanent 
posts 
1 
I Temporary 
posts 
1 
1 Source 
Existing 
resources in 
the DG or 
department 
concerned 
2 
2 Additional 
resources Duration 
5 years 
10.2. Overall financial impact of additional human resources 
(ECUs) 
Amounts Method of calculation 
Officials 
Temporary staff 
Other Ressources 
Total " ____^_____^ 
The expenses related to human resources required for the completion of this action 
will be made available upon mobilisation of existing resources: 
Officials/Temporary staff (Titles A1,A2,A4,A5): 
200,000 ECUs*5years = 1,000,000 ECUs 
10.3. Increase in other administrative expenditure as a result of the operation 
(ECUs) 
Budget heading Amounts j Method of calculation 
Tot I 1 
2.V 
The administrative expenditure required for the completion of this action will be 
made available by mobilisation of existing resources: 
(1) A-130 (Mission): 
2 missions/year for 2 officials each, thereof one to North America, one to South 
America. Duration: 7 days 
North America 
(travel: 2x 2,800 ECUs, subsistence 2x776 ECUs) 
South America 
(travel: 2x 4,500, subsistence 2x776 ECUs) 
Total A-130 (5years) 
(2) A-250 (Meetings) 7,150 ECUs 
10,750 ECUs 
88,500 ECUs 
taking place once a year alternatively in Brussels, North America, Brussels and 
South America 
Brussels 
travel costs (15 MSt delegates x 695 ECUs) 
North America 
travel costs (15 MSt delegates x 2,800 ECUs) 
South America: 
travel costs (15 MSt delegates x 4,500 ECUs) 
Annual average costs: 
(12,500 + 42,000 + 12,500 + 67,500)./. 4 = 
Total A-250 (5years) 10,425 ECUs 
42.000 ECUs 
67,500 ECUs 
33,000 ECUs 
165,000 ECUs 
53 



ISSN 0254-1475 
COM(97) 205 final 
DOCUMENTS 
EN 11 05 15 
Catalogue number : CB-CO-97-188-EN-C 
ISBN 92-78-19421-2 
Office for Official Publications of the European Communities 
L-2985 Luxembourg 
it